Aldeyra Therapeutics
ALDX
ALDX
120 hedge funds and large institutions have $252M invested in Aldeyra Therapeutics in 2023 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 41 increasing their positions, 37 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
2.18% less ownership
Funds ownership: 66.64% → 64.46% (-2.2%)
23% less capital invested
Capital invested by funds: $328M → $252M (-$75.2M)
38% less call options, than puts
Call options by funds: $1.34M | Put options by funds: $2.16M
Holders
120
Holding in Top 10
2
Calls
$1.34M
Puts
$2.16M
Top Buyers
| 1 | +$940K | |
| 2 | +$909K | |
| 3 | +$899K | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$852K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$666K |
Top Sellers
| 1 | -$4.52M | |
| 2 | -$3.12M | |
| 3 | -$1.54M | |
| 4 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$1.42M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$1.25M |